(Press-News.org) INDIANAPOLIS – The largest study of its type has found that neither vitamin E, which is an antioxidant, nor the diabetes drug metformin, successfully reduced liver enzymes in nonalcoholic fatty liver disease in children or teens, according to a paper published in the April 27, 2011 issue of Journal of the American Medical Association. The study also found that in patients with a severe type of fatty liver disease, a biopsy of the liver showed improvement in the injury pattern with vitamin E therapy.
Nonalcoholic fatty liver disease is the most common cause of chronic liver disease in children in the United States. The Indiana University School of Medicine and Riley Hospital for Children at Indiana University Health comprised one of the largest of the 10 sites nationwide that conducted the randomized, controlled trial of the disease between September 2005 and March 2010.
"Currently the only treatment for nonalcoholic fatty liver disease is diet and exercise counseling, but this is often not effective," said Jean P. Molleston, M.D., professor of clinical pediatrics at IU School of Medicine and director of pediatric gastroenterology, hepatology and nutrition at Riley at IU Health, who directed the Indiana site. "While we were disappointed that neither vitamin E nor metformin significantly reduced liver enzymes tested in blood draws from the children and teens in the study, we did note that for a subgroup of those in the study whose biopsies showed definite fatty liver hepatitis ("NASH") or many swollen liver cells ("ballooned cells"), there was improvement with vitamin E."
"Due to the risks of liver biopsy, we need to develop noninvasive markers, to be found perhaps in blood or even stool, for identification and monitoring of those who may benefit from vitamin E," she said. "We need to tackle the disease before it becomes full blown in adulthood and significantly damages the liver."
According to the Centers for Disease Control, obesity affects 17 percent of children and teens in the United States, which is three times the rate of the previous generation. Non-alcoholic fatty liver disease occurs in approximately one out of six obese children, often without symptoms. While not life threatening to children, the disease, in which fat accumulates in the liver causing it to swell, can lead to scarring of the liver, sometimes requiring transplantation in adulthood.
Nonalcoholic fatty liver disease is more prevalent in boys than girls. It is more common in Hispanics than Caucasians and is less common in African-Americans.
INFORMATION:
IU School of Medicine gastroenterologist Naga Chalasani, M.D., professor of medicine, is a co-author of the JAMA study along with researchers and clinicians from the other nine sites across the country. The study was funded by the National Institutes of Health.
The IU School of Medicine is located on the Indiana University-Purdue University Indianapolis campus.
JAMA study reports on fatty liver disease in children and teens
2011-04-29
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Melatonin might help in controlling weight gain and preventing heart diseases associated with obesity
2011-04-29
University of Granada researchers have proven that melatonin –a natural hormone produced by the body– helps in controlling weight gain –even without reducing the intake of food–, improves blood lipid profile –as it reduces triglicerids–, increases HDL cholesterol and reduces LDL cholesterol.
Melatonin is found in small quantities in some fruits and vegetables as mustard, Goji berries, almonds, sunflower seeds, cardamom, fennel, coriander and cherries. Thus, the intake of this kind of food might help in controlling weight gain and preventing heart diseases associated to ...
New gene therapy technique on iPS cells holds promise in treating immune system disease
2011-04-29
(WASHINGTON, April 28, 2011) – Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease (CGD) in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
CGD prevents neutrophils, a type of white blood cell of the immune system, from making hydrogen peroxide, an essential defense against life-threatening bacterial and fungal infections. Most cases of CGD are a result ...
New immigrants less likely to have premature babies in the first 5 years in Canada: Study
2011-04-29
TORONTO, On – April 28, 2011 – Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
"Living in poor neighbourhoods has been linked with poor health outcomes, but this study shows that this is not always the case for new Canadians," says Dr. Marcelo Urquia, epidemiologist at the Centre for Research on Inner City Health at St. Michael's Hospital. "For new immigrants, while they have an advantage on avoiding premature ...
Social bonding in prairie voles helps guide search for autism treatments
2011-04-29
Researchers at the Center for Translational Social Neuroscience (CTSN) at Emory University are focusing on prairie voles as a new model to screen the effectiveness of drugs to treat autism.
They are starting with D-cycloserine, a drug Emory researchers have shown enhances behavioral therapy for phobias and also promotes pair bonding among prairie voles. Giving female voles D-cycloserine, which is thought to facilitate learning and memory, can encourage them to bond with a new male more quickly than usual.
The results are published online and will appear in a future ...
Performance goals needed now for offshore wind turbine industry in US
2011-04-29
WASHINGTON — Structural Integrity of Offshore Wind Turbines: Oversight of Design, Fabrication, and Installation, a new report from the National Research Council's Transportation Research Board, examines standards and practices that could be used to design U.S. offshore wind installations.
In order to develop offshore wind energy in the United States, a clear set of requirements is needed, the report says. As the U.S. currently lacks standards, the committee that wrote the report recommends that the U.S. Department of the Interior's Bureau of Ocean Energy Management, ...
Crash sensor boosts safety in warehouses
2011-04-29
At the end of a long day on the job, the warehouse employee wants to deposit the last palettes quickly before heading home. With a little too much momentum he steers his forklift toward the shelf and collides with a shelf support. This is an every- day situation in large warehouses in which employees often have to maneuver goods through the narrow aisles, often under time pressure. Even harmless-seeming collisions are not really safe though, because over time they may in fact destabilize the shelf supports. In the worst case, the high-rack storage can come crashing down ...
NIH study finds Avastin and Lucentis are equally effective in treating AMD
2011-04-29
Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.
The report, from the Comparison of AMD Treatments Trials (CATT), was published online in the New England Journal of Medicine on Sunday, May 1, 2011. CATT is funded by the National Eye Institute (NEI), a part of the National Institutes of Health.
"Over ...
Extreme testing for rotor blades
2011-04-29
Only when you are standing beside a wind turbine can you appreciate the immense size of the wind turbine and its rotor blades. The largest wind turbines operating in the world today have rotor blades over 60 meters long – roughly equivalent to three truck-and-trailer units end-to-end. Within the next ten years, manufacturers of high-output wind turbines for offshore wind farms plan to produce blades up to 90 meters long. The prototypes of these new blades have to be tested and certified before they can go into production, and that requires equally as large testing facilities.
The ...
Taking safety personally
2011-04-29
A year after the BP explosion and oil spill, those trying to find someone to blame are misguided, says psychological scientist E. Scott Geller, Alumni Distinguished professor at Virginia Tech, and author of a new paper published in Current Directions in Psychological Science, a journal of the Association for Psychological Science. Geller has spent much of his 42-year career developing interventions to keep people safe, particularly helping companies develop a culture that promotes occupational safety.
There's almost never one person to blame for an injury; instead, companies ...
Inverting a standard experiment sometimes produces different results
2011-04-29
Nanoparticles will soon be used as tiny shuttles to deliver genes to cells and drugs to tumors in a more targeted way than was possible in the past.
But as the scientists prepare to use the nanoparticles in medicine, concerns have arisen about their potential toxicity.
Studies of both the applications of nanoparticles and their toxicity rely on the ability of scientists to quantify the interaction between the nanoparticles and cells, particularly the uptake (ingestion) of nanoparticles by cells.
In the standard laboratory tests of the biological activity of nanoparticles, ...